IHC 9 Markers Treatment Strategy | Lahalak Platform
A consultation that goes beyond current treatment to plan a future therapeutic path via 9 markers, predicting tumor adaptation and establishing a smart long-term strategy.
Scientific name: Immunohistochemistry (IHC) Interpretation and Consultation (9 Markers)
A strategic treatment sequencing package is available. It is based on integrated and network analysis of nine immunohistochemical (IHC) markers selected to represent a complex biological system within a tumor. The goal is to understand the dynamic interactions between different pathways and how inhibiting one pathway may activate or inhibit another...
Service type
Medical Consultation (Tissue Analysis)
Duration
30-45 minutes
Fasting
Fasting is not required
Included Services
- Advanced network analysis of nine immunological markers to understand the dynamic interactions between pathways.
- Modeling the tumor response to different sequential treatment scenarios using systems logic.
- Consultation with a multidisciplinary strategic team (oncology, pathology, pharmacy) to formulate a sequential treatment plan.
- Issue the "Mechanical Sequential Treatment Plan Report" with interaction map, sequence scenarios and final recommendation.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- Strategic vision: The demand should be driven by a desire for long-term planning, not for making an urgent remedial decision.
- Full knowledge of the options: The treating physician should have a list of treatments available and acceptable to the patient (registered, experimental at the center, etc.).
- Commitment to long-term follow-up: The plan loses its value if there is no mechanism for periodic follow-up and switching when needed.
- No need for new samples or fasting.
- Expected duration: 21 to 35 working days for complex analysis and interdisciplinary coordination.
Medical services you might also like